Work

Anlotinib plus benmelstobart as adjuvant therapy in patients with esophageal squamous cell carcinoma: A phase II clinical trial (ALTER-E005).

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.4_suppl.459

Authors: Changying Guo, Xiaobing Li, Shengjia Chen, Yongqiang Ye, Weimin Mao

Institutions: Jiangxi Provincial Cancer Hospital, Anyang Tumor Hospital, Zhejiang Cancer Hospital

Language: English

Topic: Esophageal Cancer Research and Treatment

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4406869477

Cites:

Cited by:

Related to: 10